Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy

Contributors: Vasarhelyi, Barna, Karvaly, Gellért Balázs

Subject Terms: ganciclovir, lung transplant recipients, cystic fibrosis, therapeutic drug monitoring, covariates, haloperidol, pharmacokinetics, delirium, critical ill, ICU, dapagliflozin, linagliptin, fixed-dose combination products, bioequivalence, busulfan, sulfolane, myelofibrosis, population pharmacokinetics, heart transplantation, acute rejection, tacrolimus, endomyocardial biopsies, pharmacokinetic interactions, heart transplant, precision medicine, clinical practice, gentamicin, population pharmacokinetic modeling, external evaluation, model re-estimation, dosing nomogram, long-acting antiretroviral therapy, cabotegravir, rilpivirine, pharmacokinetic simulation, TDM, plasma level, PK/PD, dose–effect relationship, LC–MS/MS, CFTR modulators, caftor, ivacaftor, lumacaftor, tezacaftor, elexacaftor, population pharmacokinetic, rivaroxaban, atrial fibrillation, direct oral anticoagulants, Thai patient, tobramycin, model-informed precision dosing, dalbavancin, long-acting, Gram-positive, osteoarticular infections, laparoscopic sleeve gastrectomy, omeprazole, modeling and simulation, obesity, treatment efficacy, medication adherence, schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, depressive disorder, cefiderocol, antibiotics, drug monitoring, isavuconazole, pediatric, pharmacodynamics, Bayesian, fungal infection, outcomes, oral anticancer drugs, oncology, imatinib, precision pharmacotherapy, cerebrospinal fluid, methotrexate, children, acute lymphoid leukemia, external validation, non-infectious uveitis (NIU), therapeutic drug monitoring (TDM), pharmacogenetics, biological therapy, limited sampling strategies, population pharmacokinetic modelling, semi-parametric simulation, robustness, area under the curve, AUC, glomerular filtration rate, GFR, tuberculosis, rifampicin, dried blood spots, limited-sampling strategy, pharmacokinetic boosting, pharmacokinetic enhancement, ritonavir, cobicistat, kinase inhibitors, small molecule kinase inhibitors, critical illness, sepsis, kidney injury, biomarkers, pediatric pharmacology, Bayesian estimation, piperacillin, tazobactam, nonparametric adaptive grid, Bayesian models, intensive care, Medicine and Nursing, Pharmacology

File Description: application/octet-stream

Access URL: https://directory.doabooks.org/handle/20.500.12854/143737
https://mdpi.com/books/pdfview/book/9781

Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation

Authors: Noppaket Singkham, Arintaya Phrommintikul, Phongsathon Pacharasupa, Lalita Norasetthada, Siriluck Gunaparn, Narawudt Prasertwitayakij, Wanwarang Wongcharoen, Baralee Punyawudho

Source: Pharmaceutics, Vol 14, Iss 8, p 1744 (2022)

Subject Terms: population pharmacokinetic, rivaroxaban, atrial fibrillation, direct oral anticoagulants, Thai patient, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1999-4923/14/8/1744; https://doaj.org/toc/1999-4923

Access URL: https://doaj.org/article/e5185ecaf3474f508081871f2d9d9a1b

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.